Appili Therapeutics Inc. Stock OTC Markets
Stocks
APLIF
CA03783R1073
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
16:31:39 10/09/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.009050 USD | 0.00% |
|
+0.55% | -38.51% |
| Market Cap | 1.32M 954K 822K 778K 706K 91.15M 1.33M 9.25M 3.56M 46.38M 3.58M 3.5M 147M | P/E 2025 |
-1.62x | P/E 2026 | -0.44x |
|---|---|---|---|---|---|
| Enterprise Value | 14.22M 10.25M 8.83M 8.36M 7.58M 979M 14.29M 99.32M 38.19M 498M 38.5M 37.65M 1.57B | EV / Sales 2025 |
152,429,607x | EV / Sales 2026 | 60,946,081x |
| Free-Float |
99.94% | Yield 2025 * |
-
| Yield 2026 | - |
OTC MarketsUSD
| Markets | Quality | ||
|---|---|---|---|
Toronto S.E.
| APLI | Delayed | |
OTC Markets
| APLIF | Delayed |
| 1 week | +0.55% | ||
| Current month | +26.39% | ||
| 1 month | +16.67% | ||
| 3 months | -14.15% | ||
| 6 months | -28.91% | ||
| Current year | -38.51% |
| 1 week | 0.01 |  | 0.01 |
| 1 month | 0.01 | | 0.01 |
| Current year | 0.01 | | 0.02 |
| 1 year | 0.01 | | 0.03 |
| 3 years | 0.01 | | 0.07 |
| 5 years | 0.01 | | 0.9 |
| 10 years | 0.01 | | 1.37 |
| Manager | Title | Age | Since |
|---|---|---|---|
Don Cilla
CEO | Chief Executive Officer | 65 | 01/11/2022 |
Kenneth Howling
DFI | Director of Finance/CFO | 68 | 16/11/2021 |
Arthur Baran
PRN | Corporate Officer/Principal | - | 01/10/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Brian Bloom
CHM | Chairman | 50 | 07/05/2015 |
| Director/Board Member | 58 | 01/10/2018 | |
Armand Balboni
CHM | Chairman | 59 | 13/11/2022 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 0.00% | +0.55% | - | - | 954K | |
| -2.11% | -1.68% | +44.52% | +95.15% | 66.93B | |
| -0.23% | -4.45% | +30.39% | +73.64% | 61.97B | |
| +1.67% | +2.47% | -11.23% | +388.34% | 28.27B | |
| -1.05% | -4.43% | +30.56% | +10.07% | 24.59B | |
| +0.34% | -6.78% | -7.27% | -17.99% | 24.3B | |
| +0.43% | -3.37% | +14.85% | -19.29% | 19.41B | |
| -3.03% | -2.29% | +185.12% | +334.07% | 16.77B | |
| -1.94% | -4.94% | -5.29% | +495.65% | 14.18B | |
| -2.28% | -4.90% | +43.64% | +155.21% | 13.91B | |
| Average | -0.82% | -3.46% | +36.14% | +168.32% | 30.04B | |
| Weighted average by Cap. | -0.84% | -3.06% | +33.46% | +133.67% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 0.1 0.07 0.06 0.06 0.05 6.92 0.1 0.7 0.27 3.52 0.27 0.27 11.12 | 0.24 0.18 0.15 0.14 0.13 16.82 0.25 1.71 0.66 8.56 0.66 0.65 27.03 |
| Net income | -2.62M -1.89M -1.63M -1.54M -1.4M -181M -2.64M -18.33M -7.05M -91.96M -7.11M -6.95M -291M | -4.24M -3.06M -2.63M -2.49M -2.26M -292M -4.26M -29.62M -11.39M -149M -11.48M -11.23M -469M |
| Net Debt | 11.07M 7.98M 6.87M 6.51M 5.9M 762M 11.12M 77.29M 29.72M 388M 29.96M 29.3M 1.23B | 12.9M 9.3M 8.01M 7.58M 6.87M 888M 12.96M 90.07M 34.64M 452M 34.91M 34.15M 1.43B |
Employees
7
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/09/26 | $0.009050 | 0.00% | 1,000 |
- Stock Market
- Stocks
- APLI Stock
- APLIF Stock
Select your edition
All financial news and data tailored to specific country editions
